Erasca, Inc. - 8-K Filing
Erasca reported Q1 2026 financial results with $408.5 million cash, up from $341.8 million at year-end 2025, and a net loss of $183.4 million ($0.60 per share), driven by R&D expenses of $27.3 million (up from $26.0 million in Q1 2025) and a one-time $150 million in-process R&D expense for expanding its ERAS-0015 licensing agreement to China, Hong Kong, and Macau. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $ERAS